Key result
Plasma soluble (pro)renin receptor levels were significantly elevated in patients with obstructive sleep apnea syndrome in parallel with disease severity, reaching 12.3 ng/mL in severe OSAS compared to 7.5 ng/mL in non-OSAS controls.
Why the study?
Does nasal continuous positive airway pressure (nCPAP) reduce plasma soluble (pro)renin receptor levels in patients with obstructive sleep apnea syndrome?
Cross-Sectional (n=289)
No
Does nasal continuous positive airway pressure (nCPAP) reduce plasma soluble (pro)renin receptor levels in patients with obstructive sleep apnea syndrome?
Absolute Event Rate: 12.3% vs 7.5%
p-value: p=<0.0001
Plasma soluble (pro)renin receptor levels are elevated in patients with obstructive sleep apnea syndrome in parallel with disease severity and are significantly reduced by continuous positive airway pressure treatment.
May mark OSAS severity; leaves open prognostic value and CPAP effects on outcomes.
(Pro)renin receptor ((P)RR), a receptor for renin and prorenin, is implicated in the pathophysiology of diabetes mellitus, hypertension and their complications. Soluble (P)RR (s(P)RR) is composed of extracellular domain of (P)RR and thus exists in blood. We have reported that plasma concentrations of s(P)RR were elevated in male patients with obstructive sleep apnea syndrome (OSAS). The aim of the present study was to clarify the difference in plasma s(P)RR concentrations between male and female OSAS patients. Plasma s(P)RR concentrations were studied in 289 subjects (206 males and 83 females) consisting of 259 OSAS patients and 30 non-OSAS control subjects. The 259 OSAS patients were classified into mild (5 ≤ apnea hypopnea index (AHI) < 15 events/h), moderate (15 ≤ AHI < 30), and severe OSAS (AHI ≥ 30). Plasma s(P)RR levels were significantly elevated in all three OSAS groups compared to non-OSAS control subjects (AHI < 5) in the entire cohort and male subjects, whereas in female subjects, the significant elevation was found only in severe OSAS. Plasma s(P)RR levels were significantly correlated with AHI in both sexes, with a higher r value found in male subjects (male r = 0.413, p < 0.0001; female r = 0.263, p < 0.05). Importantly, when OSAS patients (26 males and 15 females) with AHI ≥ 20 underwent continuous positive airway pressure treatment, plasma s(P)RR levels were significantly decreased. In conclusion, plasma s(P)RR levels are elevated in both male and female OSAS patients in parallel with the disease severity.
No takes yet. Share an insight, caveat, or question.
Nishijima et al. (2016) conducted a cross-sectional in Obstructive Sleep Apnea Syndrome (OSAS) (n=289). Severe Obstructive Sleep Apnea Syndrome (AHI ≥ 30) vs. Non-OSAS control subjects (AHI < 5) was evaluated on Plasma soluble (pro)renin receptor (s(P)RR) concentrations (p=<0.0001). Plasma soluble (pro)renin receptor levels were significantly elevated in patients with obstructive sleep apnea syndrome in parallel with disease severity, reaching 12.3 ng/mL in severe OSAS compared to 7.5 ng/mL in non-OSAS controls.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: